Frazier Life Sciences Management, L.P. Zai Lab LTD Transaction History
Frazier Life Sciences Management, L.P.
- $1.9 Billion
- Q2 2025
A detailed history of Frazier Life Sciences Management, L.P. transactions in Zai Lab LTD stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 1,308,138 shares of ZLAB stock, worth $44.9 Million. This represents 2.41% of its overall portfolio holdings.
Number of Shares
1,308,138
Previous 350,000
273.75%
Holding current value
$44.9 Million
Previous $12.6 Million
261.65%
% of portfolio
2.41%
Previous 0.8%
Shares
2 transactions
Others Institutions Holding ZLAB
# of Institutions
170Shares Held
38.6MCall Options Held
150KPut Options Held
201K-
Capital World Investors Los Angeles, CA6.04MShares$207 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY5.54MShares$190 Million2.97% of portfolio
-
Clearbridge Investments, LLC New York, NY4.01MShares$138 Million0.12% of portfolio
-
Janus Henderson Group PLC London, X02.2MShares$75.4 Million0.04% of portfolio
-
Bamco Inc New York, NY1.59MShares$54.5 Million0.16% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.36B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...